Oops: One peril of Chinese OTC BB stocks

Perhaps the most incredible thing ever — a supposed reverse merger six months in the past was not correctly consummated and now the public company is left with no assets or sales. Unsurprisingly, this involves a Chinese company trading on the horrible OTC BB:

From the China OTC Blog:

“Contrary to what we have been thinking for the last half a year, Bejing Logistics (BJGL.OB) has never had control over its Chinese subsidiary Baolong, described as China‚Äôs largest third-party logistics providers, specializing in books & magazines, agricultural products and Chinese traditional medicine storage and shipping. For today’s shocking announcement relays the fact that the merger between BJGL and Baolong was “never consummated pursuant to Chinese law” and thus null and void. If this is true, it means that BJGL has no assets, revenues, or any operations in China. This is a major blow.”

I read the China OTC Blog for fun. I would not recommend actually buying any such companies — while they may appear cheap, the risk of fraud is too great.

Disclosure: I have no position in BJGLE.O.

Leave a Reply

Your email address will not be published. Required fields are marked *

Please complete the formula below to prove that you are human * Time limit is exhausted. Please reload CAPTCHA.

This site uses Akismet to reduce spam. Learn how your comment data is processed.